Elio Cacciola, MD; Rosario Giustolisi, MD; Roberto Musso, MD; Angela Longo, BD; Emma Cacciola, MD
Cacciola E, Giustolisi R, Musso R, Longo A, Cacciola E. Antithrombin III Concentrate for Treatment of Chronic Leg Ulcers in Sickle Cell-Beta Thalassemia: A Pilot Study. Ann Intern Med. 1989;111:534-536. doi: 10.7326/0003-4819-111-6-534
Download citation file:
Published: Ann Intern Med. 1989;111(6):534-536.
Chronic leg ulcers are a common distressing complication in patients with sickle cell-beta thalassemia and are difficult to heal. The pathogenic mechanism of this complication is not known although some factors have been implicated, such as severe anemia or zinc deficiency (1, 2). In this context, however, it is significant that persons with either beta-thalassemia or sickle-cell anemia are regarded as being at thrombotic risk (3, 4).
In sickle-cell disease, the recurrent vasocclusive episodes occurring in several areas of the body have been reported to be related to the sickling, which in turn can trigger the activation of blood coagulation
Learn more about subscription options.
Register Now for a free account.
Hematology/Oncology, Red Cell Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only